3 results
Our first aim is to evaluate the validity of the developed arm leg ergometer prototype during an incremental exercise test by comparing the outcomes with a regular bicycle ergometer test. The second objective is to describe the movement of…
The primary objective is to determine if the addition of daratumumab to VRd will prolong PFS defined as the time from the date of randomization to the date of disease progression (assessed by International Myeloma Working Group [IMWG] criteria) or…
The purpose of this study is to characterize the safety and tolerability of talquetamab when administered in different combination regimens and to identify the safe dose(s) of talquetamab combination regimens.